Newman Dignan & Sheerar, Inc. Abb Vie Inc. Transaction History

Newman Dignan & Sheerar, Inc.

$585 Million
Q3 2024

A detailed history of Newman Dignan & Sheerar, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Newman Dignan & Sheerar, Inc. holds 3,930 shares of ABBV stock, worth $674,152. This represents 0.13% of its overall portfolio holdings.

Number of Shares

3,930

Previous 3,910 0.51%

Holding current value

$674,152

Previous $670,000 15.82%

% of portfolio

0.13%

Previous 0.17%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $3,276 - $3,986	20 Added 0.51%	3,930 $776,000
Q2 2024 Jul 15, 2024	SELL	$154.79 - $180.76 $3,095 - $3,615	-20 Reduced 0.51%	3,910 $670,000
Q1 2024 Apr 26, 2024	SELL	$159.82 - $182.1 $6,232 - $7,101	-39 Reduced 0.98%	3,930 $715,000
Q4 2023 Feb 08, 2024	BUY	$137.6 - $154.97 $546,134 - $615,075	3,969 New	3,969 $615,000
Q2 2023 Aug 02, 2023	SELL	$132.51 - $164.9 $35,777 - $44,523	-270 Reduced 6.29%	4,020 $541,000
Q1 2023 Apr 28, 2023	SELL	$144.61 - $166.54 $7,230 - $8,327	-50 Reduced 1.15%	4,290 $683,000
Q4 2022 Jan 20, 2023	BUY	$138.31 - $165.87 $5,394 - $6,468	39 Added 0.91%	4,340 $0
Q3 2022 Oct 18, 2022	BUY	$134.21 - $153.93 $11,944 - $13,699	89 Added 2.11%	4,301 $577,000
Q2 2022 Aug 03, 2022	SELL	$137.62 - $174.96 $6,881 - $8,748	-50 Reduced 1.17%	4,212 $645,000
Q1 2022 Apr 14, 2022	BUY	$131.98 - $163.75 $49,492 - $61,406	375 Added 9.65%	4,262 $691,000
Q4 2021 Jan 18, 2022	SELL	$107.43 - $135.93 $2,148 - $2,718	-20 Reduced 0.51%	3,887 $526,000
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $3,156 - $3,516	-30 Reduced 0.76%	3,907 $440,000
Q4 2020 Jan 29, 2021	SELL	$80.49 - $108.67 $24,147 - $32,601	-300 Reduced 7.08%	3,937 $422,000
Q3 2020 Oct 14, 2020	BUY	$85.91 - $100.83 $52,061 - $61,102	606 Added 16.69%	4,237 $371,000
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $35,217 - $47,126	480 Added 15.23%	3,631 $349,000
Q1 2020 Apr 20, 2020	SELL	$64.5 - $97.79 $26,122 - $39,604	-405 Reduced 11.39%	3,151 $258,000
Q3 2019 Oct 21, 2019	SELL	$62.98 - $75.72 $6,298 - $7,572	-100 Reduced 2.74%	3,556 $269,000
Q1 2019 Apr 09, 2019	SELL	$77.14 - $90.79 $30,084 - $35,408	-390 Reduced 9.64%	3,656 $295,000
Q3 2018 Oct 25, 2018	BUY	$88.91 - $98.84 $6,490 - $7,215	73 Added 1.84%	4,046 $382,000
Q1 2018 Apr 17, 2018	BUY	$92.01 - $123.21 $31,559 - $42,261	343 Added 9.45%	3,973 $365,000
Q4 2017 Jan 29, 2018	SELL	$89.56 - $98.21 $33,585 - $36,828	-375 Reduced 9.36%	3,630 $351,000
Q3 2017 Oct 18, 2017	SELL	$69.85 - $89.22 $13,969 - $17,844	-200 Reduced 4.76%	4,005 $356,000
Q2 2017 Aug 08, 2017	BUY	N/A	4,205	4,205 $305,000

Others Institutions Holding ABBV

# of Institutions

3,863

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Newman Dignan & Sheerar, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newman Dignan & Sheerar, Inc. with notifications on news.

Account

Newman Dignan & Sheerar, Inc. Abb Vie Inc. Transaction History